Excitation–contraction coupling inhibitors potentiate the actions of botulinum neurotoxin type A at the neuromuscular junction
Mickaël Machicoane(Centre National de la Recherche Scientifique), Marco Pirazzini(University of Padua)
Cited by 1
Related Papers
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
|Pharmacological Reviews|2017|740
SLK-dependent activation of ERMs controls LGN–NuMA localization and spindle orientation
|The Journal of Cell Biology|2014|100